PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
Negative FDA AdCom vote for Intercept’s obeticholic acid in NASH
Sentiment towards Brexit has worsened three years after UK left EU
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Novartis touts breast cancer win with “landmark” Kisqali results
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK
China’s NMPA approves Vascepa for hypertriglyceridemia
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
University of Sydney will use AI to boost cancer drug research
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
Who’s acquiring who? M&A activity in the pharmaceutical industry in Japan decreased by 5% in Q1 2023
Who’s investing where? Private equity deal activity in the pharmaceutical industry in The US decreased by 27% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Communications in life sciences: Uncovering the Unlocked survey results
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
All articles by Niklas Wallin Bernhardsson
Niklas Wallin Bernhardsson
Pricing and Market Access
Barriers to market access for innovative medicines increase in the COVID era
View more
Most Popular
Eikon Therapeutics bag $106m to fund eager acquisitions
Coherus allies with Mark Cuban to challenge AbbVie for Humira biosimilar
CMS mandates registry data for coverage of Alzheimer’s drugs
